Spread and evolution of Plasmodium falciparum drug resistance

Parasitology International

Volumn 58, Issue 3, 2009, Pages 201-209

  Mita, Toshihiro ^a   Tanabe, Kazuyuki ^b   Kita, Kiyoshi ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

dhfr; Drug resistance; Evolution; Malaria; pfcrt; Spread

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR;

DHFR GENE; DHPS GENE; DRUG RESISTANCE; GENE; GEOGRAPHIC DISTRIBUTION; MALARIA; NONHUMAN; PFCRT GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; POPULATION GENETICS; PRIORITY JOURNAL; REVIEW;

AFRICA; ANIMALS; ANTIMALARIALS; ASIA; DRUG RESISTANCE; EVOLUTION, MOLECULAR; HUMANS; MALARIA, FALCIPARUM; PACIFIC ISLANDS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SOUTH AMERICA;

PLASMODIUM FALCIPARUM;

EID: 67650397861     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2009.04.004     Document Type: Review

References (135)

1. Gregson A., and Plowe C.V. Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev 57 (2005) 117-145
2. Ekland E.H., and Fidock D.A. Advances in understanding the genetic basis of antimalarial drug resistance. Curr Opin Microbiol 10 (2007) 363-370
3. Cortese J.F., Caraballo A., Contreras C.E., and Plowe C.V. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis 186 (2002) 999-1006
4. Wootton J.C., Feng X., Ferdig M.T., Cooper R.A., Mu J., Baruch D.I., et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418 (2002) 320-323
5. Nair S., Williams J.T., Brockman A., Paiphun L., Mayxay M., Newton P.N., et al. A selective sweep driven by pyrimethamine treatment in Southeast Asian malaria parasites. Mol Biol Evol 20 (2003) 1526-1536
6. Roper C., Pearce R., Bredenkamp B., Gumede J., Drakeley C., Mosha F., et al. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 361 (2003) 1174-1181
7. Roper C., Pearce R., Nair S., Sharp B., Nosten F., and Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science 305 (2004) 1124
8. McCollum A.M., Poe A.C., Hamel M., Huber C., Zhou Z., Shi Y.P., et al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis 194 (2006) 189-197
9. Mita T., Tanabe K., Takahashi N., Tsukahara T., Eto H., Dysoley L., et al. Independent evolution of pyrimethamine resistance in Plasmodium falciparum isolates in Melanesia. Antimicrob Agents Chemother 51 (2007) 1071-1077
10. Maiga O., Djimde A.A., Hubert V., Renard E., Aubouy A., Kironde F., et al. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J Infect Dis 196 (2007) 165-172
11. McCollum A.M., Mueller K., Villegas L., Udhayakumar V., and Escalante A.A. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob Agents Chemother 51 (2007) 2085-2091
12. McCollum A.M., Basco L.K., Tahar R., Udhayakumar V., and Escalante A.A. Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistant alleles in a population from central Africa. Antimicrob Agents Chemother 52 (2008) 4089-4097
13. Mita T., Tanabe K., Takahashi N., Culleton R., Ndounga M., Dzodzomenyo M., et al. Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa. J Antimicrob Chemother 63 (2009) 252-255
14. Hyde J.E. Exploring the folate pathway in Plasmodium falciparum. Acta Trop 94 (2005) 191-206
15. Fidock D.A., Eastman R.T., Ward S.A., and Meshnick S.R. Recent highlights in antimalarial drug resistance and chemotherapy research. Trends Parasitol 24 (2008) 537-544
16. Orjih A.U., Ryerse J.S., and Fitch C.D. Hemoglobin catabolism and the killing of intraerythrocytic Plasmodium falciparum by chloroquine. Experientia 50 (1994) 34-39
17. Fidock D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6 (2000) 861-871
18. Sanchez C.P., McLean J.E., Rohrbach P., Fidock D.A., Stein W.D., and Lanzer M. Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 44 (2005) 9862-9870
19. Warhurst D.C., Craig J.C., and Adagu I.S. Lysosomes and drug resistance in malaria. Lancet 360 (2002) 1527-1529
20. Krogstad D.J., Gluzman I.Y., Herwaldt B.L., Schlesinger P.H., and Wellems T.E. Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem Pharmacol 43 (1992) 57-62
21. Sanchez C.P., Rohrbach P., McLean J.E., Fidock D.A., Stein W.D., and Lanzer M. Differences in trans-stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum. Mol Microbiol 64 (2007) 407-420
22. Lehane A.M., and Kirk K. Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite's digestive vacuole. Antimicrob Agents Chemother 52 (2008) 4374-4380
23. Martin R.E., and Kirk K. The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. Mol Biol Evol 21 (2004) 1938-1949
24. Johnson D.J., Owen A., Plant N., Bray P.G., and Ward S.A. Drug-regulated expression of Plasmodium falciparum P-glycoprotein homologue 1: a putative role for nuclear receptors. Antimicrob Agents Chemother 52 (2008) 1438-1445
25. Foote S.J., Thompson J.K., Cowman A.F., and Kemp D.J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57 (1989) 921-930
26. Wilson C.M., Serrano A.E., Wasley A., Bogenschutz M.P., Shankar A.H., and Wirth D.F. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244 (1989) 1184-1186
27. Cowman A.F., Karcz S., Galatis D., and Culvenor J.G. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol 113 (1991) 1033-1042
28. Foote S.J., Kyle D.E., Martin R.K., Oduola A.M., Forsyth K., Kemp D.J., et al. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345 (1990) 255-258
29. von Seidlein L., Duraisingh M.T., Drakeley C.J., Bailey R., Greenwood B.M., and Pinder M. Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. Trans R Soc Trop Med Hyg 91 (1997) 450-453
30. Duraisingh M.T., Jones P., Sambou I., von Seidlein L., Pinder M., and Warhurst D.C. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 108 (2000) 13-23
31. Babiker H.A., Pringle S.J., Abdel-Muhsin A., Mackinnon M., Hunt P., and Walliker D. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J Infect Dis 183 (2001) 1535-1538
32. Nagesha H.S., Din S., Casey G.J., Susanti A.I., Fryauff D.J., Reeder J.C., et al. Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia. Trans R Soc Trop Med Hyg 95 (2001) 43-49
33. Haruki K., Bray P.G., Ward S.A., Hommel M., and Ritchie G.Y. Chloroquine resistance of Plasmodium falciparum: further evidence for a lack of association with mutations of the pfmdr1 gene. Trans R Soc Trop Med Hyg 88 (1994) 694
34. Thomas S.M., Ndir O., Dieng T., Mboup S., Wypij D., Maguire J.H., et al. In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. Am J Trop Med Hyg 66 (2002) 474-480
35. Basco L.K., and Ringwald P. pfmdr1 gene mutation and clinical response to chloroquine in Yaounde, Cameroon. Trans R Soc Trop Med Hyg 91 (1997) 210-211
36. Pillai D.R., Labbe A.C., Vanisaveth V., Hongvangthong B., Pomphida S., Inkathone S., et al. Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis 183 (2001) 789-795
37. Duraisingh M.T., and Cowman A.F. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 94 (2005) 181-190
38. Durand R., Jafari S., Vauzelle J., Delabre J.F., Jesic Z., and Le Bras J. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Mol Biochem Parasitol 114 (2001) 95-102
39. Mita T., Kaneko A., Hombhanje F., Hwaihwanje I., Takahashi N., Osawa H., et al. Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea. Acta Trop 98 (2006) 137-144
40. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., and Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403 (2000) 906-909
41. Chen N., Russell B., Fowler E., Peters J., and Cheng Q. Levels of chloroquine resistance in Plasmodium falciparum are determined by loci other than pfcrt and pfmdr1. J Infect Dis 185 (2002) 405-407
42. Duraisingh M.T., von Seidlein L.V., Jepson A., Jones P., Sambou I., Pinder M., et al. Linkage disequilibrium between two chromosomally distinct loci associated with increased resistance to chloroquine in Plasmodium falciparum. Parasitology 121 (2000) 1-7
43. Adagut I.S., and Warhurst D.C. Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria. Parasitology 123 (2001) 219-224
44. Djimde A., Doumbo O.K., Cortese J.F., Kayentao K., Doumbo S., Diourte Y., et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344 (2001) 257-263
45. Kublin J.G., Cortese J.F., Njunju E.M., Mukadam R.A., Wirima J.J., Kazembe P.N., et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 187 (2003) 1870-1875
46. Mita T., Kaneko A., Lum J.K., Bwijo B., Takechi M., Zungu I.L., et al. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 68 (2003) 413-415
47. Mita T., Kaneko A., Lum J.K., Zungu I.L., Tsukahara T., Eto H., et al. Expansion of wild type allele rather than back mutation in pfcrt explains the recent recovery of chloroquine sensitivity of Plasmodium falciparum in Malawi. Mol Biochem Parasitol 135 (2004) 159-163
48. Laufer M.K., Thesing P.C., Eddington N.D., Masonga R., Dzinjalamala F.K., Takala S.L., et al. Return of chloroquine antimalarial efficacy in Malawi. N Engl J Med 355 (2006) 1959-1966
49. Bzik D.J., Li W.B., Horii T., and Inselburg J. Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proc Natl Acad Sci U S A 84 (1987) 8360-8364
50. Brooks D.R., Wang P., Read M., Watkins W.M., Sims P.F., and Hyde J.E. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224 (1994) 397-405
51. Triglia T., and Cowman A.F. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci U S A 91 (1994) 7149-7153
52. Peterson D.S., Walliker D., and Wellems T.E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci U S A 85 (1988) 9114-9118
53. Foote S.J., Galatis D., and Cowman A.F. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci U S A 87 (1990) 3014-3017
54. Basco L.K., Eldin de Pecoulas P., Wilson C.M., Le Bras J., and Mazabraud A. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69 (1995) 135-138
55. Nzila-Mounda A., Mberu E.K., Sibley C.H., Plowe C.V., Winstanley P.A., and Watkins W.M. Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob Agents Chemother 42 (1998) 164-169
56. Hyde J.E. Antifolate resistance in Africa and the 164-dollar question. Trans R Soc Trop Med Hyg 102 (2008) 301-303
57. Triglia T., Menting J.G., Wilson C., and Cowman A.F. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A 94 (1997) 13944-13949
58. Triglia T., Wang P., Sims P.F., Hyde J.E., and Cowman A.F. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. Embo J 17 (1998) 3807-3815
59. de Beer T.A., Louw A.I., and Joubert F. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase. Bioorg Med Chem 14 (2006) 4433-4443
60. Harinasuta T., Suntharasamai P., and Viravan C. Chloroquine-resistant falciparum malaria in Thailand. Lancet 2 (1965) 657-660
61. WHO. chemotherapy of malaria and resistance to antimalarials. WHO Technical Report Series (1973) 529
62. WHO. Advances in malaria chemotherapy. WHO Technical Report Series (1984) 711
63. Vathsala P.G., Pramanik A., Dhanasekaran S., Devi C.U., Pillai C.R., Subbarao S.K., et al. Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT in P. falciparum malaria in India. Am J Trop Med Hyg 70 (2004) 256-259
64. Dittrich S., Alifrangis M., Stohrer J.M., Thongpaseuth V., Vanisaveth V., Phetsouvanh R., et al. Falciparum malaria in the north of Laos: the occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT. Trop Med Int Health 10 (2005) 1267-1270
65. Lim P., Chy S., Ariey F., Incardona S., Chim P., Sem R., et al. pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia. Antimicrob Agents Chemother 47 (2003) 87-94
66. Durrand V., Berry A., Sem R., Glaziou P., Beaudou J., and Fandeur T. Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro. Mol Biochem Parasitol 136 (2004) 273-285
67. Campbell C.C., Chin W., Collins W.E., Teutsch S.M., and Moss D.M. Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet 2 (1979) 1151-1154
68. Fogh S., Jepsen S., and Effersoe P. Chloroquine-resistant Plasmodium falciparum malaria in Kenya. Trans R Soc Trop Med Hyg 73 (1979) 228-229
69. Eichenlaub D., and Pohle H.D. A case of chloroquine-resistant (R1) falciparum malaria from the East African Comoros Islands (author's transl). Infection 8 (1980) 90-92
70. Aronsson B., Bengtsson E., Bjorkman A., Pehrson P.O., Rombo L., and Wahlgren M. Chloroquine-resistant falciparum malaria in Madagascar and Kenya. Ann Trop Med Parasitol 75 (1981) 367-373
71. Onori E. The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara. Bull World Health Organ 62 Suppl (1984) 55-62
72. Ekue J.M., Ulrich A.M., and Njelesani E.K. Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia. Br Med J 286 (1983) 1315-1316
73. Overbosch D., van den Wall Bake A.W., Stuiver P.C., and van der Kaay H.J. Chloroquine-resistant falciparum malaria from Malawi. Trop Geogr Med 36 (1984) 71-72
74. Martinez Rodriguez R., Perez Rodriguez A., Perez Avila J., Ruiz Perez A., and Lazo Lopetegui O. Plasmodium falciparum malaria resistant to 4-aminoquinoline drugs. Report of the first imported case from the People's Republic of Angola. Rev Cubana Med Trop 37 (1985) 2-6
75. Isaacson M., Cox G.A., and Sieling W.L. Chloroquine resistant Plasmodium falciparum malaria in Namibia. Lancet 2 (1984) 42
76. Ekanem O.J. Plasmodium falciparum infection not responding to chloroquine in Nigeria. Trans R Soc Trop Med Hyg 79 (1985) 141-142
77. Le Bras J., Hatin I., Bouree P., Coco-Cianci O., Garin J.P., Rey M., et al. Chloroquine-resistant falciparum malaria in Benin. Lancet 2 (1986) 1043-1044
78. Bouree P., Coco Cianci O., and Bisaro F. Chloroquine-resistant Plasmodium falciparum in Togo. Presse Med 16 (1987) 1760
79. Neequaye J., Coeene J., Taelman H., Wéry M., Greenberg A.E., Minns G., et al. In vivo chloroquine-resistant falciparum malaria in western Africa. Lancet 1 (1986) 153-154
80. Brandicourt O., Druilhe P., Diouf F., Brasseur P., Turk P., and Danis M. Decreased sensitivity to chloroquine and quinine of some Plasmodium falciparum strains from Senegal in September 1984. Am J Trop Med Hyg 35 (1986) 717-721
81. Menon A., Snow R.W., Otoo L., and Greenwood B.M. Decline in sensitivity of Plasmodium falciparum to chloroquine in The Gambia. Lancet 1 (1987) 1029-1030
82. Adubofour K.O. Drug resistance in malaria: a review of the West African situation. J Natl Med Assoc 84 (1992) 1025-1029
83. Mehlotra R.K., Mattera G., Bockarie M.J., Maguire J.D., Baird J.K., Sharma Y.D., et al. Discordant patterns of genetic variation at two chloroquine resistance loci in worldwide populations of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 52 (2008) 2212-2222
84. Alifrangis M., Dalgaard M.B., Lusingu J.P., Vestergaard L.S., Staalsoe T., Jensen A.T., et al. Occurrence of the Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J Infect Dis 193 (2006) 1738-1741
85. Nagesha H.S., Casey G.J., Rieckmann K.H., Fryauff D.J., Laksana B.S., Reeder J.C., et al. New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolates. Am J Trop Med Hyg 68 (2003) 398-402
86. Severini C., Menegon M., Sannella A.R., Paglia M.G., Narciso P., Matteelli A., et al. Prevalence of pfcrt point mutations and level of chloroquine resistance in Plasmodium falciparum isolates from Africa. Infect Genet Evol 6 (2006) 262-268
87. Zakeri S., Afsharpad M., Kazemzadeh T., Mehdizadeh K., Shabani A., and Djadid N.D. Association of pfcrt but not pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum. Am J Trop Med Hyg 78 (2008) 633-640
88. Meuwissen J.H. The use of medicated salt in an antimalaria campaign in West New Guinea. Trop Geogr Med 16 (1964) 245-255
89. Ebisawa I., and Fukuyama T. Chloroquine resistance of Plasmodium falciparum in West Irian and East Kalimantan. Ann Trop Med Parasitol 69 (1975) 275-282
90. Clyde D.F., McCarthy V.C., Miller R.M., and Hornick R.B. Chloroquine-resistant falciparum malaria from Irian Jaya (Indonesian New Guinea). J Trop Med Hyg 79 (1976) 38-41
91. Han C.M., and Grimmond T.R. Chloroquine resistance trials in Papua New Guinea. 1. Maprik and Popondetta areas. P N G Med J 19 (1976) 236-242
92. Pribadi W., Dakung L.S., Gandahusada S., and Daldyono. Chloroquine resistant Plasmodium falciparum infection from Lampung and South Sumatra, Indonesia. Southeast Asian J Trop Med Public Health 12 (1981) 69-73
93. Smrkovski L.L., Hoffman S.L., Purnomo, Hussein R.P., Masbar S., and Kurniawan L. hloroquine resistant Plasmodium falciparum on the island of Flores, Indonesia. Trans R Soc Trop Med Hyg 77 (1983) 459-462
94. Sakihama N., Ohmae H., Bakote'e B., Kawabata M., Hirayama K., and Tanabe K. Limited allelic diversity of Plasmodium falciparum merozoite surface protein 1 gene from populations in the Solomon Islands. Am J Trop Med Hyg 74 (2006) 31-40
95. Tanabe K., Sakihama N., and Kaneko A. Stable SNPs in malaria antigen genes in isolated populations. Science 303 (2004) 493
96. Huaman M.C., Yoshinaga K., Suryanatha A., Suarsana N., and Kanbara H. Short report: polymorphisms in the chloroquine resistance transporter gene in Plasmodium falciparum isolates from Lombok, Indonesia. Am J Trop Med Hyg 71 (2004) 40-42
97. Sakihama N., Nakamura M., Palanca Jr. A.A., Argubano R.A., Realon E.P., Larracas A.L., et al. Allelic diversity in the merozoite surface protein 1 gene of Plasmodium falciparum on Palawan Island, the Philippines. Parasitol Int 56 (2007) 185-194
98. Chen N., Wilson D.W., Pasay C., Bell D., Martin L.B., Kyle D., et al. Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant pfcrt alleles in the Philippines. Antimicrob Agents Chemother 49 (2005) 2102-2105
99. Moore D.V., and Lanier J.E. Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg 10 (1961) 5-9
100. Box E.D., Box Q.T., and Young M.D. Chloroquine-resistant Plasmodium falciparum from Porto Velho, Brazil. Am J Trop Med Hyg 12 (1963) 300-304
101. Ferraroni J.J., Speer C.A., Hayes J., and Suzuki M. Prevalence of chloroquine-resistant falciparum malaria in the Brazilian Amazon. Am J Trop Med Hyg 30 (1981) 526-530
102. Contreras C.E., Cortese J.F., Caraballo A., and Plowe C.V. Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar. Am J Trop Med Hyg 67 (2002) 400-405
103. Vieira P.P., Ferreira M.U., Alecrim M.G., Alecrim W.D., da Silva L.H., Sihuincha M.M., et al. pfcrt Polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon Basin. J Infect Dis 190 (2004) 417-424
104. Takechi M., Matsuo M., Ziba C., MacHeso A., Butao D., Zungu I.L., et al. Therapeutic efficacy of sulfadoxine/pyrimethamine and susceptibility in vitro of P. falciparum isolates to sulfadoxine-pyremethamine and other antimalarial drugs in Malawian children. Trop Med Int Health 6 (2001) 429-434
105. Mayor A.G., Gomez-Olive X., Aponte J.J., Casimiro S., Mabunda S., Dgedge M., et al. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. J Infect Dis 183 (2001) 1413-1416
106. Schwenke A., Brandts C., Philipps J., Winkler S., Wernsdorfer W.H., and Kremsner P.G. Declining chloroquine resistance of Plasmodium falciparum in Lambarene, Gabon from 1992 to 1998. Wien Klin Wochenschr 113 (2001) 63-64
107. Nguyen M.H., Davis T.M., Cox-Singh J., Hewitt S., Tran Q.T., Tran B.K., et al. Treatment of uncomplicated falciparum malaria in southern Vietnam: can chloroquine or sulfadoxine-pyrimethamine be reintroduced in combination with artesunate?. Clin Infect Dis 37 (2003) 1461-1466
108. Liu D.Q., Liu R.J., Ren D.X., Gao D.Q., Zhang C.Y., Qui C.P., et al. Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Bull World Health Organ 73 (1995) 483-486
109. Archibald H.M. Preliminary field trials on a new schizonticide. Br Med J 2 (1951) 821-823
110. Clyde D.F., and Shute G.T. Resistance of East African varieties of Plasmodium falciparum to pyrimethamine. Trans R Soc Trop Med Hyg 48 (1954) 495-500
111. Jones S.A. Resistance of P. falciparum and P. malariae to pyrimethamine (daraprim) following mass treatment with this drug; a preliminary note. East Afr Med J 31 (1954) 47-49
112. Burgess R.W., and Young M.D. The development of pyrimethamine resistance by Plasmodium falciparum. Bull World Health Organ 20 (1959) 37-46
113. Meuwissen J.H. Resistance of Plasmodium falciparum to pyrimethamine and proguanil in Netherlands New Guinea. Am J Trop Med Hyg 10 (1961) 135-139
114. Rumans L.W., Dennis D.T., and Atmosoedjono S. Fansidar resistant falciparum malaria in Indonesia. Lancet 2 (1979) 580-581
115. Black F., Bygbjerg I., Effersoe P., Gomme G., Jepsen S., and Jensen G.A. Fansidar resistant falciparum malaria acquired in South East Asia. Trans R Soc Trop Med Hyg 75 (1981) 715-716
116. Nurse G.T. Fansidar-resistant falciparum malaria in Papua New Guinea. Lancet 1 (1981) 36-37
117. Mberu E.K., Mosobo M.K., Nzila A.M., Kokwaro G.O., Sibley C.H., and Watkins W.M. The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. Am J Trop Med Hyg 62 (2000) 396-401
118. Bjorkman A., and Phillips-Howard P.A. The epidemiology of drug-resistant malaria. Trans R Soc Trop Med Hyg 84 (1990) 177-180
119. Khim N., Bouchier C., Ekala M.T., Incardona S., Lim P., Legrand E., et al. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Antimicrob Agents Chemother 49 (2005) 3147-3152
120. Cox-Singh J., Zakaria R., Abdullah M.S., Rahman H.A., Nagappan S., and Singh B. Short report: differences in dihydrofolate reductase but not dihydropteroate synthase alleles in Plasmodium falciparum isolates from geographically distinct areas in Malaysia. Am J Trop Med Hyg 64 (2001) 28-31
121. Nash D., Nair S., Mayxay M., Newton P.N., Guthmann J.P., Nosten F., et al. Selection strength and hitchhiking around two anti-malarial resistance genes. Proc Biol Sci 272 (2005) 1153-1161
122. Toma H., Imada Y., Vannachone B., Miyagi M., Kobayashi J., Uechi G., et al. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR. Southeast Asian J Trop Med Public Health 36 (2005) 602-604
123. Certain L.K., Briceno M., Kiara S.M., Nzila A.M., Watkins W.M., and Sibley C.H. Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987-2006. J Infect Dis 197 (2008) 1743-1751
124. Mita T., Kaneko A., Hwaihwanje I., Tsukahara T., Takahashi N., Osawa H., et al. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea. Infect Genet Evol 6 (2006) 447-452
125. Verdrager J. Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia. J Trop Med Hyg 89 (1986) 277-289
126. Gabaldon A., and Guerrero L. An attempt to eradicate malaria by the weekly administration of pyrimethamine in areas of out-of-doors transmission in Venezuela. Am J Trop Med Hyg 8 (1959) 433-439
127. Maberti S. The development of resistance to pyrimethamine. Presentation of 15 cases studied in Trujillo, Venezuela. Arch Venez Med Trop Parasitol Med 3 (1960) 239-259
128. Walker A.J., and Lopez-Antunano F.J. Response to drugs of South American strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg 62 (1968) 654-667
129. Godoy G.A., Volcan G.S., Guevara R., Medrano C., Castro J., and Texeira A. Venezuelan strains of Plasmodium falciparum resistant to sulfa and pyrimethamine as demonstrated by in vitro test. Rev Latinoam Microbiol 19 (1977) 229-231
130. Espinal C.A., Cortes G.T., Guerra P., and Arias A.E. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am J Trop Med Hyg 34 (1985) 675-680
131. Kremsner P.G., Zotter G.M., Feldmeier H., Graninger W., Kollaritsch M., Wiedermann G., et al. In vitro drug sensitivity of Plasmodium falciparum in Acre, Brazil. Bull World Health Organ 67 (1989) 289-293
132. Cortese J.F., and Plowe C.V. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Mol Biochem Parasitol 94 (1998) 205-214
133. Vasconcelos K.F., Plowe C.V., Fontes C.J., Kyle D., Wirth D.F., Pereira da Silva L.H., et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. Mem Inst Oswaldo Cruz 95 (2000) 721-728
134. Zhou Z., Griffing S.M., de Oliveira A.M., McCollum A.M., Quezada W.M., Arrospide N., et al. Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru. Antimicrob Agents Chemother 52 (2008) 739-741
135. Hastings I.M. The origins of antimalarial drug resistance. Trends Parasitol 20 (2004) 512-518